Neonatal seizures.
In childhood, the risk for seizures is greatest in the neonatal period. Currently used therapies have limited efficacy. Although the treatment of neonatal seizures has not significantly changed in the past several decades, there has been substantial progress in understanding developmental mechanisms that influence seizure generation and responsiveness to anticonvulsants. This review includes an overview of current approaches to the diagnosis and treatment of neonatal seizures, identifies some of the critical factors that have limited progress, and highlights recent insights about the pathophysiology of neonatal seizures that may provide the foundation for better treatment.
Silverstein
Faye S
FS
Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-0646, USA. fsilvers@med.umich.edu
Jensen
Frances E
FE
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D006801:Humans; D007231:Infant, Newborn; D012640:Seizures / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*
D000927:Anticonvulsants